| Name | Value |
|---|---|
| Revenues | 51.0K |
| Cost of Revenue | 187.0K |
| Gross Profit | -136.0K |
| Operating Expense | 3,934.0K |
| Operating I/L | -4,070.0K |
| Other Income/Expense | 384.0K |
| Interest Income | 0.0K |
| Pretax | -3,686.0K |
| Income Tax Expense | 0.0K |
| Net Income/Loss | -3,686.0K |
Helius Medical Technologies, Inc. is a neurotechnology company specializing in non-invasive technologies for treating symptoms of neurological disease or trauma. Its flagship product, the Portable Neuromodulation Stimulator (PoNS), is a non-surgical medical device designed for short-term treatment of gait deficit in multiple sclerosis and balance deficit in mild-to-moderate traumatic brain injury. The device is used in conjunction with supervised therapeutic exercise, offering a unique solution for patients. Helius generates revenue through the development, licensing, and acquisition of innovative medical technologies, positioning itself as a leader in the neurotechnology industry.